BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25988864)

  • 1. IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL.
    Fang Y; Chen X; Bai Q; Qin C; Mohamud AO; Zhu Z; Ball TW; Ruth CM; Newcomer DR; Herrick EJ; Nicholl MB
    J Surg Oncol; 2015 Jun; 111(8):969-74. PubMed ID: 25988864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-32α has differential effects on proliferation and apoptosis of human melanoma cell lines.
    Nicholl MB; Chen X; Qin C; Bai Q; Zhu Z; Davis MR; Fang Y
    J Surg Oncol; 2016 Mar; 113(4):364-9. PubMed ID: 27100023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for resveratrol as a radiation sensitizer for melanoma treatment.
    Fang Y; Bradley MJ; Cook KM; Herrick EJ; Nicholl MB
    J Surg Res; 2013 Aug; 183(2):645-53. PubMed ID: 23522452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artichoke as a melanoma growth inhibitor.
    Mathew AM; Deng Z; Nelson CJ; Mayberry TG; Bai Q; Lequio M; Fajardo E; Xiao H; Wakefield MR; Fang Y
    Med Oncol; 2023 Aug; 40(9):262. PubMed ID: 37544953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.
    Fang Y; Zhao L; Xiao H; Cook KM; Bai Q; Herrick EJ; Chen X; Qin C; Zhu Z; Wakefield MR; Nicholl MB
    Med Oncol; 2017 Feb; 34(2):23. PubMed ID: 28058630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax.
    Balabanov D; Zhao L; Zhu Z; Hunzeker ZE; Tonner HM; Ding VA; Wakefield MR; Bai Q; Fang Y
    Anticancer Res; 2019 Jul; 39(7):3493-3498. PubMed ID: 31262873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
    Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Petrotetrayndiol A induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells through cytochrome c-mediated activation of caspases.
    Choi HJ; Yee SB; Park SE; Im E; Jung JH; Chung HY; Choi YH; Kim ND
    Cancer Lett; 2006 Feb; 232(2):214-25. PubMed ID: 16458118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells.
    Lin SY; Lai WW; Chou CC; Kuo HM; Li TM; Chung JG; Yang JH
    Melanoma Res; 2006 Dec; 16(6):509-19. PubMed ID: 17119452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.
    Lee HL; Park MH; Song JK; Jung YY; Kim Y; Kim KB; Hwang DY; Yoon do Y; Song MJ; Han SB; Hong JT
    Oncotarget; 2016 Apr; 7(17):23425-38. PubMed ID: 26993600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
    Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
    Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the Power of Kiwifruit for Radiosensitization of Melanoma.
    Kou L; Zhu Z; Fajardo E; Bai Q; Redington C; Xiao H; Lequio M; Sham N; Wakefield MR; Fang Y
    Anticancer Res; 2021 Dec; 41(12):5945-5951. PubMed ID: 34848448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
    Zeng G; Liu J; Chen H; Liu B; Zhang Q; Li M; Zhu R
    Oncol Rep; 2014 Jun; 31(6):2713-9. PubMed ID: 24789439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative--Enhancement of both extrinsic and intrinsic apoptosis pathways.
    Berger A; Quast SA; Plötz M; Hein M; Kunz M; Langer P; Eberle J
    Biochem Pharmacol; 2011 Jan; 81(1):71-81. PubMed ID: 20858462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.
    Lashinger LM; Zhu K; Williams SA; Shrader M; Dinney CP; McConkey DJ
    Cancer Res; 2005 Jun; 65(11):4902-8. PubMed ID: 15930312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells.
    Kadowaki Y; Chari NS; Teo AE; Hashi A; Spurgers KB; McDonnell TJ
    Apoptosis; 2011 Jun; 16(6):627-35. PubMed ID: 21437722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of kiwifruit extract for treatment of melanoma.
    Kou L; Zhu Z; Redington C; Bai Q; Wakefield M; Lequio M; Fang Y
    Med Oncol; 2021 Feb; 38(3):25. PubMed ID: 33586074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.